Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Dandruff can affect confidence and should be treated with proper shampoos or medical advice.

Lighter skin types respond better to narrowband UVB therapy for cutaneous T-cell lymphoma than darker skin types.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

IL-27 may help prevent hair loss in alopecia areata by promoting immunosuppressive T cells.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Certain immune cells, when activated by specific signals, can encourage hair growth.

The role of γδT-cells in causing alopecia areata remains unclear.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Finasteride increases CD8+ T cells in BPH tissues.

FGF9 from certain T cells helps create new hair follicles during wound healing, which could potentially be used for hair loss treatments.

A substance called FGF9 from certain immune cells can trigger new hair growth during wound healing in mice, but humans may not have the same response due to fewer of these cells.

FGF9 from certain cells can trigger new hair growth during wound healing, but humans have fewer of these cells, which may limit hair regrowth.

Blocking certain proteins on immune cells may help treat alopecia areata.